4//SEC Filing
Einhorn Andrew J. 4
Accession 0001104659-22-007844
CIK 0001739426other
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 4:31 PM ET
Size
5.8 KB
Accession
0001104659-22-007844
Insider Transaction Report
Form 4
Einhorn Andrew J.
Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2022-01-24$1.13/sh−9,607$10,856→ 141,473 total
Holdings
- 22,852(indirect: By family limited liability company)
Ordinary Shares
Footnotes (1)
- [F1]The Reporting Person is the sole managing member of the limited liability company and, as a result, may be deemed to beneficially own the ordinary shares held by the limited liability company. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Documents
Issuer
RVL Pharmaceuticals plc
CIK 0001739426
Entity typeother
Related Parties
1- filerCIK 0001560685
Filing Metadata
- Form type
- 4
- Filed
- Jan 25, 7:00 PM ET
- Accepted
- Jan 26, 4:31 PM ET
- Size
- 5.8 KB